# Cannabinoid Clinical Trials: Teen Cannabis Intervention Study > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/adolescent-cannabis-use-disorder-intervention/ > **Published:** 2026-04-18T19:02:43-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:18:59-04:00 > **Clinical Summary:** Explore adolescent cannabis use disorder intervention through clinical trials focusing on teen cannabis use and treatment strategies. --- ✦ New CED Clinical Relevance  #90High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic Adolescent Medicine[Cannabis Use Disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/)InterventionNeurodevelopment[Clinical Trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) Why This Matters [Adolescent cannabis use](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/) carries significant neurodevelopmental risks during critical brain maturation periods. Evidence-based intervention strategies for teen [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) disorder are limited, making rigorous clinical trial data essential for informing therapeutic approaches in this vulnerable population. Clinical Summary This appears to reference clinical trial work examining interventions for [adolescent cannabis use](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/), though specific study details are not provided in the source material. Teen [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) can impair cognitive development, academic performance, and increase risk for [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/) in adulthood. Current evidence supports that earlier intervention generally produces better outcomes, but optimal therapeutic modalities remain under investigation. Dr. Caplan’s Take “Without seeing the actual trial data, I can’t evaluate the specific intervention’s merit. What I can say is that any teen cannabis intervention must balance harm reduction with realistic expectations about adolescent behavior patterns.” Clinical Perspective 🧠 Clinicians should remain alert for signs of problematic cannabis use in adolescent patients, including declining academic performance, social withdrawal, or persistent use despite negative consequences. Family-based interventions and motivational interviewing techniques currently show the strongest evidence base for teen substance use disorders. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Cannabinoid%20Clinical%20Trials%3A%20Teen%20Cannabis%20Intervention%20Study%20-%20CED%20Clinic%20%40drcaplan&url=https%3A//cedclinic.com/cannabinoid-clinical-trials-teen-cannabis-intervention-study-2/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//cedclinic.com/cannabinoid-clinical-trials-teen-cannabis-intervention-study-2/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Cannabinoid%20Clinical%20Trials%3A%20Teen%20Cannabis%20Intervention%20Study%20-%20CED%20Clinic%20--%20via%20%40drcaplan.bsky.social%20https%3A//cedclinic.com/cannabinoid-clinical-trials-teen-cannabis-intervention-study-2/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://cedclinic.com/cannabinoid-clinical-trials-teen-cannabis-intervention-study-2/](https://cedclinic.com/rebuttal-based-social-norms-tailored-cannabis-intervention/) Table of Contents - [FAQ](#FAQ)[What makes this cannabis research clinically relevant?](#What_makes_this_cannabis_research_clinically_relevant) - [Why is adolescent cannabis use particularly concerning?](#Why_is_adolescent_cannabis_use_particularly_concerning) - [What is Cannabis Use Disorder?](#What_is_Cannabis_Use_Disorder) - [What types of interventions are effective for adolescent cannabis users?](#What_types_of_interventions_are_effective_for_adolescent_cannabis_users) - [How does cannabis affect adolescent brain development?](#How_does_cannabis_affect_adolescent_brain_development) - [Related](#Related) ## FAQ #### What makes this cannabis research clinically relevant? This study has been rated with high clinical relevance (#90) due to its strong evidence and direct clinical implications. The research provides actionable insights for healthcare providers treating adolescent cannabis use disorders. #### Why is adolescent cannabis use particularly concerning? Cannabis use during adolescence can significantly impact neurodevelopment, as the brain continues developing into the mid-twenties. Early intervention is crucial to prevent long-term cognitive and developmental consequences. #### What is Cannabis Use Disorder? Cannabis Use Disorder is a clinical condition characterized by problematic cannabis use that leads to significant impairment or distress. It includes symptoms like tolerance, withdrawal, and inability to control use despite negative consequences. #### What types of interventions are effective for adolescent cannabis users? Evidence-based interventions for adolescents typically include behavioral therapies, family-based treatments, and motivational interviewing. Early intervention programs show the most promise for preventing progression to more severe use disorders. #### How does cannabis affect adolescent brain development? Cannabis can disrupt normal neurodevelopmental processes during adolescence, potentially affecting memory, attention, and executive function. The developing brain is particularly vulnerable to THC’s effects on neural connectivity and maturation. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Study of 11000 US Teens Links Cannabis Use to Slower Brain Development – Science Alert](https://cedclinic.com/cannabis-use-adolescent-brain-maturation-risks-study/) This study highlights the impact of cannabis use on [adolescent brain development](https://cedclinic.com/adolescent-cb1-receptor-antagonism-social-behavior/), emphasizing the importance of early intervention. [Read More](https://cedclinic.com/cannabis-use-adolescent-brain-maturation-risks-study/) [UC San Diego study: Marijuana use affects teen brains](https://cedclinic.com/adolescent-brain-development-cannabis-risks-ucsd-study/) Research from UC San Diego explores how marijuana use alters brain function in teenagers, underscoring clinical concerns. [Explore Study](https://cedclinic.com/adolescent-brain-development-cannabis-risks-ucsd-study/) [Tween, Teen Cannabis Use Linked to Slower Cognitive Development – Psychiatry Advisor](https://cedclinic.com/early-adolescent-cannabis-use-risks-cognitive-development/) This article discusses the cognitive development delays associated with cannabis use in tweens and teens, relevant for clinical interventions. [Learn More](https://cedclinic.com/early-adolescent-cannabis-use-risks-cognitive-development/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).